Orgenesis Inc. (145) | Uncategorized (89)
Recent Contracts
-
Executive Directorship Agreement between the Company and Vered Caplan dated November 19, 2020
(Filed With SEC on March 9, 2021)
-
Description of Securities
(Filed With SEC on March 9, 2020)
-
Transfer Agreement, dated as of August 7, 2019 by and among Masthercell Global, Orgenesis Inc. and GPP-II Masthercell, LLC
(Filed With SEC on August 13, 2019)
-
Controlled Equity OfferingSM Sales Agreement, dated December 20, 2018, by and between Orgenesis Inc. and Cantor Fitzgerald & Co
(Filed With SEC on December 20, 2018)
-
Form of Convertible Note convertible into Units or Hemogenyx Securities
(Filed With SEC on December 14, 2018)
-
Form of Convertible Note convertible into Units or Immungenyx Securities
(Filed With SEC on December 14, 2018)
-
Form of Warrant included in Units
(Filed With SEC on December 14, 2018)
-
Form of Subscription Agreement, dated December 10, 2018, by and between the Company and investor
(Filed With SEC on December 14, 2018)
-
Form of Subscription Agreement, dated December 10, 2018, by and between the Company and investor
(Filed With SEC on December 14, 2018)
-
Form of Convertible Note convertible into Units or Hemogenyx Securities
(Filed With SEC on December 6, 2018)
-
Form of Convertible Note convertible into Units or Immungenyx Securities
(Filed With SEC on December 6, 2018)
-
Form of Warrant included in Units
(Filed With SEC on December 6, 2018)
-
Form of Subscription Agreement, dated November 30, 2018, by and between the Company and investor
(Filed With SEC on December 6, 2018)
-
Form of Subscription Agreement, dated November 30, 2018, by and between the Company and investor
(Filed With SEC on December 6, 2018)
-
Form of Convertible Note convertible into Units or Hemogenyx Securities
(Filed With SEC on November 28, 2018)
-
Form of Convertible Note convertible into Units or Immugenyx Securities
(Filed With SEC on November 28, 2018)
-
Form of Warrant included in Units
(Filed With SEC on November 28, 2018)
-
Form of Subscription Agreement, dated November 21, 2018, by and between the Company and investor
(Filed With SEC on November 28, 2018)
-
Form of Subscription Agreement, dated November 21, 2018, by and between the Company and investor
(Filed With SEC on November 28, 2018)
-
Form of Convertible Note convertible into Units or Hemogenyx Securities
(Filed With SEC on November 20, 2018)
-
Form of Convertible Note convertible into Units or Immungenyx Securities
(Filed With SEC on November 20, 2018)
-
Form of Warrant included in Units
(Filed With SEC on November 20, 2018)
-
Subscription Agreement, dated November 13, 2018, by and between the Company and Avner Sonnino
(Filed With SEC on November 20, 2018)
-
Subscription Agreement, dated November 13, 2018, by and between the Company and Avner Sonnino
(Filed With SEC on November 20, 2018)
-
Collaboration and License Agreement, dated as of June 18, 2018, between Orgenesis Inc. and Mircod Limited
(Filed With SEC on October 12, 2018)
-
Collaboration and License Agreement, dated as of June 19, 2018, between Orgenesis Inc. and Mircod Limited
(Filed With SEC on July 17, 2018)
-
Advisory Services Agreement dated as of June 27, 2018 between Masthercell Global Inc. and Great Point Partners LLC
(Filed With SEC on June 29, 2018)
-
Stock Purchase Agreement dated as of June 27, 2018 by and among Orgenesis Inc., Masthercell Global Inc. and GPP-II Masthercell, LLC
(Filed With SEC on June 29, 2018)
-
Masthercell Global Inc. Stockholders Agreement dated as of June 27, 2018 by and among Masthercell Global Inc., GPP-II Masthercell LLC and Orgenesis Inc
(Filed With SEC on June 29, 2018)
-
Contribution Assignment and Assumption Agreement dated as of June 27, 2018 by and among Masthercell Global Inc. and Orgenesis Inc
(Filed With SEC on June 29, 2018)
-
Technology Transfer Agreement dated as of June 27, 2018 between Orgenesis Inc. and Masthercell Global Inc
(Filed With SEC on June 29, 2018)
-
Amended and Restated Certificate of Incorporation of Masthercell Global Inc. dated as of June 27, 2018 to be filed with the Secretary of State of the State of Delaware
(Filed With SEC on June 29, 2018)
-
Executive Employment Agreement dated as of March 30, 2017 between Orgensis Inc. and Vered Caplan
(Filed With SEC on July 24, 2017)
-
Amendment No. 1 dated May 10, 2017 to Executive Employment Agreement dated as of March 30, 2017 between Orgensis Inc. and Vered Caplan
(Filed With SEC on July 24, 2017)
-
Joint Venture Agreement dated as of May 10, 2016 between Orgenesis Inc. and Atvio Biotech Ltd
(Filed With SEC on April 19, 2017)
-
Private Placement Subscription Agreement dated January 26, 2017 between Orgenesis Inc. and Image Securities FZC
(Filed With SEC on April 19, 2017)
-
Amendment No. 1 dated February 9, 2017 to the Private Placement Subscription Agreement between Orgenesis Inc. and Image Securities FZC
(Filed With SEC on April 19, 2017)
-
Joint Venture Agreement
(Filed With SEC on February 28, 2017)
-
Release Agreement, dated as of November 18, 2016 among Orgenesis Maryland Inc., Scott Carmer and Orgenesis Inc
(Filed With SEC on November 23, 2016)
-
Strategic Advisory Agreement dated as of November 18, 2016 between Orgenesis Inc. and Scott Carmer
(Filed With SEC on November 23, 2016)